Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. The Bridge Message Board

Why they pushing this shot so hard unless they are

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 127017
(Total Views: 332)
Posted On: 12/24/2021 12:48:58 PM
Avatar
Posted By: john1234
Re: Steel Reserve #74760
Quote:
Why they pushing this shot so hard unless they are compensated for it. I could not care less what you do so don't care what I do with my body. This whole administration needs to go.
Quote:


BMJ. 2005 Jan 22; 330(7484): 162.
doi: 10.1136/bmj.330.7484.162-a
PMCID: PMC545012
PMID: 15661767
Royalty payments to staff researchers cause new NIH troubles

Patients who took part in clinical trials at the US National Institutes of Health (NIH) had no idea that scientists at the institutes received $8.9m (£4.8m; €6.8m) in royalty payments and might benefit financially for the use of their discoveries by pharmaceutical companies and device makers, reports from Associated Press allege. This information was not made public until the press agency obtained the information after filing a request under the Freedom of Information Act.

The press agency has reported that 916 present and former NIH researchers received annual royalty payments averaging $9700 but could receive as much as $150 000.

At the same time, NIH researchers spent millions of taxpayers' dollars studying the treatments that they had developed that were licensed to drug companies, the agency reported.

A patient advocacy group, the Alliance for Human Research Protection, says that patients might have thought differently about the risks of trial treatment if they knew of scientists' financial interests.

The NIH has been criticised before for not disclosing conflicts of interest (BMJ 2004;329: 10 [Google Scholar]). Five years ago, just before leaving office, Donna Shalala, then secretary of the federal Department of Health and Human Services, issued a requirement that scientists disclose their financial interests. But nothing happened until the Associated Press's investigations.

The NIH has received almost $56m in royalties for its discoveries, the agency says. This money is put back into its research.

The press agency reported that two leading researchers, Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and his deputy, Clifford Lane, received payments relating to their development of interleukin 2 as a treatment for HIV/AIDS. Dr Lane told the BMJ that the payment was part of his federal compensation. He explained that the government patented the development and shared the payments it received with the inventors. Since 1997 he has received about $45 000 he says. The institutes awarded $36m in grants for studies to test the treatment.

Dr Anthony Fauci told the BMJ that as a government employee he was required by law to put his name on the patent for the development of interleukin 2 and was also required by law to receive part of the payment the government received for use of the patent. He said that he felt it was inappropiate to receive payment and donated the entire amount to charity.

Both doctors told Associated Press that they had been concerned about an apparent conflict of interest for some time before the agency's story appeared.

The BMJ was told by an NIH spokesperson that the NIH had no plans to put information about payments to its researchers on its website and that the BMJ would have to make a request via the Freedom of Information Act to find out royalty payments to individual researchers.

source
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545012/


Moderna offers NIH co-ownership of COVID vaccine patent amid dispute with government

https://www.cbsnews.com/news/moderna-covid-va...es-health/




(1)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us